$CRUS

CIRRUS LOGIC, INC. (CRUS): Results of Operations and Financial Condition

CIRRUS LOGIC, INC. (CRUS) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.2 3 shareholderletter.htm EX-99.2 Document Exhibit 99.2 Q1 FY27 Letter to Shareholders August 5, 2026 August 5, 2026 Dear Shareholders, In Q1 FY27, Cirrus Logic delivered record first quarter revenue of $460 million as well as record first quarter GAAP and non-GAAP earnings

Original reporting
Published Aug 5, 2026, 8:01 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 5, 2026, 8:06 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$CRUS
Bullish
high confidence
Mentioned
$CRUS
Relevance
9/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$CRUSBullishHigh
01

Why it matters

Traders can update models using the disclosed Q1 FY27 results (revenue, GAAP and non-GAAP EPS, gross margin) and the September-quarter guidance ranges for revenue and gross margin, plus the stated PC headwind drivers.

02

Market read

Fresh quarterly results and explicit forward guidance for revenue and gross margin are likely to drive immediate estimate revisions and positioning.

03

What to watch

One customer contributes about 90% of revenue, so any change in that customer’s design activity or shipment schedule could dominate the quarter-to-quarter outcome despite record headline numbers.

Relevance 9/10Novelty 9/10Timing: filed after-hours today, guidance for the September quarter disclosed

Background

The SEC 8-K includes Item 2.02 results of operations and financial condition, with an Exhibit 99.2 Q1 FY27 letter to shareholders.

Company-level read

Ticker impact

$CRUSBullishHigh confidence
Context

Cirrus Logic reports Q1 FY27 record revenue of $460M and EPS of $1.47 GAAP, plus September-quarter revenue guidance of $510M to $570M.

Expected impact

Near-term volatility likely around the guided September-quarter revenue range and gross margin outlook, with smartphone strength offset by PC timing pressure.

Evidence & confidence

This is a primary SEC 8-K shareholder letter disclosure with explicit revenue, EPS, gross margin, and guidance ranges, which typically drives immediate repricing versus prior expectations.

Market effects

Signals demand strength in smartphone custom components and AI-enabled PC codecs, while highlighting supply-chain constraints affecting PC-related revenue timing.

No explicit regional demand or regulatory impacts disclosed.

Mentions customer PC announcements based on NVIDIA’s RTX Spark platform, linking Cirrus content to broader AI PC ecosystem momentum.

Counterpoint

PC revenue weakness is framed as timing, but the magnitude of the lowered FY27 expectations could indicate a more durable demand or supply mismatch.

Key entities

  • Cirrus Logic, Inc.

    CRUS reports Q1 FY27 record revenue and EPS, and provides September-quarter revenue and gross margin guidance in its shareholder letter.

  • GlobalFoundries

    Company expects a temporary gross margin benefit in Q2 from wafers purchased under prior agreements at favorable pricing.

  • NVIDIA

    Letter cites multiple customers announcing new PCs based on NVIDIA’s RTX Spark platform, expected to ship later this year with Cirrus amplifiers and codecs.

Related articles

$CRUSMedAI 9/10

Cirrus Logic Reports Record Fiscal Q1 2027 Results

Cirrus Logic reported record fiscal Q1 2027 revenue of $459.7M for the quarter ended June 27, 2026, with GAAP EPS of $1.47 and non-GAAP EPS of $1.84, and GAAP gross margin of 52.6%. For Q2, it guided revenue to $510M-$570M and GAAP gross margin of 52%-54%, with GAAP R&D and SG&A of $163M-$169M. Management cited smartphone demand and AI PC codec interest.

Med

CareCloud, Inc. Q2 2026 Earnings Call Summary

CareCloud, Inc. reported 16% Q2 2026 revenue growth, citing Medsphere integration and a shift to recurring technology-enabled solutions at 75% of revenue. The company fully redeemed Series B preferred stock, removing about $3.3M annual dividends, and reaffirmed full-year 2026 guidance. It also acquired Empower Healthcare and Compliance Partners to expand into compliance and audit defense, and set a $60M ATM equity program.

$MRNAMedAI 8/10

Moderna (MRNA) Q2 2026 Earnings Call Transcript

Moderna’s Q2 2026 earnings call covered pipeline updates and financial results. The company said it will add a Phase III cohort for norovirus vaccine mRNA-1403 after an interim analysis, and reported Q2 revenue of $145 million, net loss of $782 million, and cash and investments of $6.9 billion. Moderna reiterated 2026 revenue growth up to 10% and updated cost guidance.

$GEOMed

The GEO Group, Inc. Q2 2026 Earnings Call Summary

GEO Group reported Q2 2026 earnings call updates. Management said contract wins normalized, adding about $520 million in annual revenue, and ICE populations at GEO facilities rose 20% after baseline appropriations were restored. Guidance was raised, capex expected below $100M in 2027, and GEO plans to shift toward selling facility real estate while keeping long-term operations.